Sort
48,018 grants matching “immunotherapy”
Project #1 Bar and Shaw
$399,176Katharine June Bar · University Of Pennsylvania · P01 · FY2018 · AI
PEDIATRIC ONCOLOGY GROUP--PHASE I TRIALS IN CHILDREN
$399,163Northwestern University · U01 · FY2000 · CA
Role of KAT5 in lung cancer
$399,154Susumu Kobayashi · Beth Israel Deaconess Medical Center · R01 · FY2021 · CA
Immunotherapy For Latex Rubber Allergy
$399,144N Franklin Adkinson · Johns Hopkins University · R01 · FY2006 · AI
Regulation of memory CD8 T cell development
$399,144Susan M Kaech · Yale University · R01 · FY2006 · AI
Targeting DDX3 for triple-negative breast cancer treatment
$399,129Venu Raman · Johns Hopkins University · R21 · FY2025 · CA
Role of type 2 immune response in pancreatic cancer tumorigenesis
$399,058Prasenjit Dey · Roswell Park Cancer Institute Corp · R01 · FY2023 · CA
PROTAC Targeting of Tip60 in Syngeneic Cancer Models Using Cereblon Knock-in Mice
$399,051Wayne William Hancock · Children'S Hosp Of Philadelphia · R01 · FY2021 · CA
Epigenesis of Cell Fate Potential
$399,048Andrew S Koh · University Of Chicago · R35 · FY2022 · GM
Epigenesis of Cell Fate Potential
$399,048Andrew S Koh · University Of Chicago · R35 · FY2020 · GM
Epigenesis of Cell Fate Potential
$399,048Andrew S Koh · University Of Chicago · R35 · FY2024 · GM
Epigenesis of Cell Fate Potential
$399,048Andrew S Koh · University Of Chicago · R35 · FY2021 · GM
Epigenesis of Cell Fate Potential
$399,048Andrew S Koh · University Of Chicago · R35 · FY2023 · GM
Single-cell and imaging data integration software to spatially resolve the tumor microenvironment
$399,041Elana Fertig · Johns Hopkins University · U01 · FY2022 · CA
Optimizing Therapeutic STING Agonism in Triple Negative Breast Cancer
$399,032Thanh Uyen Barbie · Dana-Farber Cancer Inst · R01 · FY2023 · CA
Antigen-independent prediction and biomarker identification of cancer-specific T cells
$399,032Bo Li · Children'S Hosp Of Philadelphia · R01 · FY2023 · CA
Mouse Infection Core
$399,008Ann E. Jerse · Henry M. Jackson Fdn For The Adv Mil/Med · U19 · FY2015 · AI
The B7x pathways in the tumor microenvironment
$399,000Xingxing Zang · Albert Einstein College Of Medicine · R01 · FY2025 · CA
Enhance Cancer Therapeutics with 3-in-1 CAR T Cells
$398,997Jianping Huang · Immunogenik, Inc. · R41 · FY2025 · CA
Advancing cancer therapy: Developing antibody blockade targeting a novel immune checkpoint, LAIR1/CD305
$398,997Jianping Huang · Immunogenik, Inc. · R41 · FY2025 · CA
Novel immunotherapeutic potential of DGKalpha inhibition for glioblastoma
$398,997Benjamin W. Purow · University Of Virginia · R01 · FY2023 · NS
Research Testbed 1
$398,992Paolo Provenzano · University Of Minnesota · U54 · FY2023 · CA
Cancer Center Research Training Program
$398,967John M Maris · University Of Pennsylvania · T32 · FY2015 · CA
Antibodies as Catalysts
$398,925Scripps Research Institute · R01 · FY2001 · GM
NOVEL STRATEGIES FOR THE IMMUNOTHERAPY OF COLON CANCER
$398,925Scripps Research Institute · R01 · FY2000 · CA